Vanguard Group’s BIND THERAPEUTICS INC BIND Stock Holding History

Vanguard Group’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-495,864	Closed	-$1.09M	–	4215
2016 Q1	$1.09M	Buy	495,864 +300	+0.1%	+$544	﹤0.01%	3570
2015 Q4	$1.14M	Buy	495,564 +31,828	+7%	+$129K	﹤0.01%	3583
2015 Q3	$2.07M	Buy	463,736 +11,754	+3%	+$57.7K	﹤0.01%	3364
2015 Q2	$2.53M	Buy	451,982 +24,280	+6%	+$151K	﹤0.01%	3323
2015 Q1	$2.35M	Buy	427,702 +244,424	+133%	+$1.5M	﹤0.01%	3334
2014 Q4	$990K	Buy	183,278 +4,428	+2%	+$33.2K	﹤0.01%	3533
2014 Q3	$1.54M	Buy	178,850 +44,065	+33%	+$434K	﹤0.01%	3368
2014 Q2	$1.78M	Sell	134,785 -6,557	-5%	-$64.2K	﹤0.01%	3310
2014 Q1	$1.69M	Buy	141,342 +80,383	+132%	+$1.05M	﹤0.01%	3293
2013 Q4	$920K	Buy	+60,959	New	+$776K	﹤0.01%	3440

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Vanguard Group's BIND Position: Q2 2016 in Review

Vanguard Group sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 495,864 shares — an estimated $1.09M sold.

Vanguard Group first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $2.53M in Q2 2015. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

Vanguard Group reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
Vanguard Group sold 495,864 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $1.09M.
Vanguard Group first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
Vanguard Group's BIND THERAPEUTICS INC position peaked at $2.53M in Q2 2015.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Vanguard Group's 13F filing for Q2 2016, filed 10 Aug 2016.